This document provides an overview of the approach to diagnosing and treating posterior uveitis. It discusses the importance of a thorough clinical assessment to narrow the differential diagnosis and guide diagnostic testing. Common causes of posterior uveitis include infectious diseases like tuberculosis, toxoplasmosis, and viral infections, as well as non-infectious conditions like Behcet's disease, sarcoidosis, and VKH syndrome. Standard diagnostic tests include bloodwork, chest x-ray, fluorescein angiography, and OCT. Targeted testing depends on clinical features and may include vitreous biopsy and serologic testing. Characterization of the uveitis based on features like laterality, site of inflammation, and morphology
This document discusses various types of uveitis including classification, signs, symptoms, complications, investigations, and treatments. It covers infective causes like toxoplasmosis, tuberculosis, syphilis, and fungal infections. It also discusses immune-mediated uveitis associated with conditions like VKH syndrome, Behcet's disease, and sarcoidosis. Intermediate uveitis is characterized by inflammation of the pars plana, peripheral retina, and choroid. Posterior uveitis involves the retina and choroid and can be caused by infections, autoimmune diseases, or unknown etiologies.
Central retinal artery occlusion (CRAO) results from obstruction of blood flow through the central retinal artery, causing ischemia of the inner retina. It presents with sudden, painless vision loss. Examination typically reveals a cherry red spot at the macula and whitening of the inner retina. Ancillary testing such as OCT, FFA, and ERG can help evaluate the extent of retinal damage. Prompt diagnosis and treatment of underlying causes is important to prevent further vascular events.
Peripheral ulcerative keratitis (PUK) is a destructive inflammatory disease of the peripheral cornea characterized by epithelial defects, stromal thinning and infiltration, and potential perforation. It can be caused by autoimmune, infectious, or inflammatory processes. Treatment involves topical lubricants, antibiotics, corticosteroids, and systemic immunosuppressants depending on severity and underlying etiology to stop corneal melting and promote healing. A thorough workup is needed to identify any associated systemic diseases.
This document discusses peripheral ulcerative keratitis (PUK), a group of inflammatory diseases that cause thinning and ulceration of the peripheral cornea. It describes several types of PUK including Mooren's ulcer, marginal keratitis, Terrien's marginal degeneration, and PUK associated with autoimmune diseases. Mooren's ulcer is a rare autoimmune disease characterized by progressive, peripheral, circumferential ulceration. Marginal keratitis is caused by a hypersensitivity reaction to Staphylococcus exotoxins. Terrien's marginal degeneration causes thinning of the peripheral cornea. PUK associated with autoimmune diseases like rheumatoid arthritis is linked to immune complex deposition in the peripheral cornea. Management involves topical
Posner-Schlossman syndrome is characterized by recurrent unilateral attacks of ocular hypertension accompanied by mild anterior chamber inflammation. It was first described in 1948 and affects people aged 20-50, with males and females equally impacted. The exact pathogenesis is unknown but may involve trabecular meshwork obstruction by mononuclear cells. Symptoms include blurred vision and eye discomfort. Signs include elevated IOP out of proportion to mild inflammation and open iridocorneal angles. While usually self-limiting, long-term damage from recurrent attacks can occur, so treatment focuses on IOP control and inflammation management medically or surgically if needed.
Uveitis classification & clinical features 1lijulk
Uveitis is inflammation of the uvea, which includes the iris, ciliary body, and choroid. It is classified based on anatomy, clinical course, etiology, and histology. The Standardization of Uveitis Nomenclature (SUN) Working Group developed standardized classifications including anatomical (anterior, intermediate, posterior, panuveitis), descriptors (onset, duration, course), and grading systems. Clinical features depend on the involved area and can include symptoms like pain, photophobia, blurred vision, and floaters. Signs on examination may reveal cells and flare in the anterior chamber, keratic precipitates, hypopyon, synechiae, and lesions of the iris, retina, or
This document provides information on anterior ischemic optic neuropathy (AION), which is the most common cause of acute optic neuropathy in older age groups. It can be divided into two types: arteritic AION, which is due to giant cell arteritis; and non-arteritic AION, which makes up most cases. Both types present with sudden painless vision loss and optic disc swelling. Arteritic AION carries a worse prognosis and requires high-dose steroid treatment to prevent loss of vision in the fellow eye. Non-arteritic AION has a variable course but generally a poor rate of recovery without any proven effective treatments.
This document discusses scleritis and episcleritis, inflammation of the sclera and outer layer of the sclera. It describes the anatomy of the sclera and classifications of scleritis and episcleritis. Episcleritis is a benign recurrent inflammation of the outer episcleral tissue. Scleritis is a more serious chronic inflammation of the sclera proper that can cause vision loss. Both have a variety of etiologies including autoimmune disorders and infections. Clinical features, investigations, and treatments are outlined.
This document discusses various types of uveitis including classification, signs, symptoms, complications, investigations, and treatments. It covers infective causes like toxoplasmosis, tuberculosis, syphilis, and fungal infections. It also discusses immune-mediated uveitis associated with conditions like VKH syndrome, Behcet's disease, and sarcoidosis. Intermediate uveitis is characterized by inflammation of the pars plana, peripheral retina, and choroid. Posterior uveitis involves the retina and choroid and can be caused by infections, autoimmune diseases, or unknown etiologies.
Central retinal artery occlusion (CRAO) results from obstruction of blood flow through the central retinal artery, causing ischemia of the inner retina. It presents with sudden, painless vision loss. Examination typically reveals a cherry red spot at the macula and whitening of the inner retina. Ancillary testing such as OCT, FFA, and ERG can help evaluate the extent of retinal damage. Prompt diagnosis and treatment of underlying causes is important to prevent further vascular events.
Peripheral ulcerative keratitis (PUK) is a destructive inflammatory disease of the peripheral cornea characterized by epithelial defects, stromal thinning and infiltration, and potential perforation. It can be caused by autoimmune, infectious, or inflammatory processes. Treatment involves topical lubricants, antibiotics, corticosteroids, and systemic immunosuppressants depending on severity and underlying etiology to stop corneal melting and promote healing. A thorough workup is needed to identify any associated systemic diseases.
This document discusses peripheral ulcerative keratitis (PUK), a group of inflammatory diseases that cause thinning and ulceration of the peripheral cornea. It describes several types of PUK including Mooren's ulcer, marginal keratitis, Terrien's marginal degeneration, and PUK associated with autoimmune diseases. Mooren's ulcer is a rare autoimmune disease characterized by progressive, peripheral, circumferential ulceration. Marginal keratitis is caused by a hypersensitivity reaction to Staphylococcus exotoxins. Terrien's marginal degeneration causes thinning of the peripheral cornea. PUK associated with autoimmune diseases like rheumatoid arthritis is linked to immune complex deposition in the peripheral cornea. Management involves topical
Posner-Schlossman syndrome is characterized by recurrent unilateral attacks of ocular hypertension accompanied by mild anterior chamber inflammation. It was first described in 1948 and affects people aged 20-50, with males and females equally impacted. The exact pathogenesis is unknown but may involve trabecular meshwork obstruction by mononuclear cells. Symptoms include blurred vision and eye discomfort. Signs include elevated IOP out of proportion to mild inflammation and open iridocorneal angles. While usually self-limiting, long-term damage from recurrent attacks can occur, so treatment focuses on IOP control and inflammation management medically or surgically if needed.
Uveitis classification & clinical features 1lijulk
Uveitis is inflammation of the uvea, which includes the iris, ciliary body, and choroid. It is classified based on anatomy, clinical course, etiology, and histology. The Standardization of Uveitis Nomenclature (SUN) Working Group developed standardized classifications including anatomical (anterior, intermediate, posterior, panuveitis), descriptors (onset, duration, course), and grading systems. Clinical features depend on the involved area and can include symptoms like pain, photophobia, blurred vision, and floaters. Signs on examination may reveal cells and flare in the anterior chamber, keratic precipitates, hypopyon, synechiae, and lesions of the iris, retina, or
This document provides information on anterior ischemic optic neuropathy (AION), which is the most common cause of acute optic neuropathy in older age groups. It can be divided into two types: arteritic AION, which is due to giant cell arteritis; and non-arteritic AION, which makes up most cases. Both types present with sudden painless vision loss and optic disc swelling. Arteritic AION carries a worse prognosis and requires high-dose steroid treatment to prevent loss of vision in the fellow eye. Non-arteritic AION has a variable course but generally a poor rate of recovery without any proven effective treatments.
This document discusses scleritis and episcleritis, inflammation of the sclera and outer layer of the sclera. It describes the anatomy of the sclera and classifications of scleritis and episcleritis. Episcleritis is a benign recurrent inflammation of the outer episcleral tissue. Scleritis is a more serious chronic inflammation of the sclera proper that can cause vision loss. Both have a variety of etiologies including autoimmune disorders and infections. Clinical features, investigations, and treatments are outlined.
White dot syndromes are a group of diseases characterized by inflammation of the outer retina, retinal pigment epithelium, and choroid. They include conditions like birdshot retinochoroidopathy, multifocal choroiditis and panuveitis, and acute posterior multifocal placoid pigment epitheliopathy. Symptoms include blurred vision, photopsias, and visual field changes. Treatment involves corticosteroids and immunosuppressive drugs. Prognosis depends on the specific condition but many white dot syndromes resolve spontaneously without long-term vision loss.
Macular hole is a defect in the macula involving its full thickness. It was first described in 1869. Idiopathic macular holes are the most common type and affect people over age 55. Staging of macular holes ranges from stage 1 to 4 based on size and pathology. Symptoms include decreased vision and metamorphopsia. Diagnosis involves examination, OCT, and sometimes FA. Treatment is usually vitrectomy surgery for stages 2-4 to relieve traction on the macula. Prognosis depends on pre-op vision and hole size/duration, with most patients gaining vision after surgery.
Congenital retinal anomalies can arise from developmental defects, vascular abnormalities, infections, tumors or trauma. Clinical presentation depends on laterality and extent of vision loss. Examination may reveal colobomas, retinal folds, persistent fetal vasculature or lacunae indicative of conditions like Aicardi syndrome. Retinopathy of prematurity is a major cause of vision loss in premature infants and progresses through stages from demarcation lines to retinal detachment. Infectious etiologies can cause chorioretinitis from viruses like cytomegalovirus and parasites including toxoplasmosis. Prompt treatment is aimed at the underlying cause and prevention of complications affecting vision.
This document provides an overview of central serous chorioretinopathy (CSC), including its pathogenesis, clinical presentation, diagnosis, course and treatment. CSC is characterized by a localized serous retinal detachment in the macula due to leakage of fluid from the choroid. It typically affects men ages 30-50 and can be associated with stress, corticosteroid use, hypertension and type A personality. Diagnosis is usually clinical but can be confirmed with fluorescein angiography showing characteristic leakage patterns or optical coherence tomography identifying subretinal fluid. While most cases resolve spontaneously, laser photocoagulation or photodynamic therapy may be used in persistent or recurrent cases to seal leaking sites and accelerate resolution.
This document discusses ocular tuberculosis. It begins with an introduction to tuberculosis as a systemic disease caused by Mycobacterium tuberculosis. It then covers the clinical criteria for systemic TB disease and laboratory diagnostic criteria. It discusses the pathophysiology, transmission, and pathogenesis of TB infection. The document outlines various clinical presentations of ocular TB including anterior uveitis, intermediate uveitis, posterior segment manifestations, neuro-ophthalmic manifestations, adnexal involvement, and drug-related ocular toxicity. Investigations for diagnosing ocular TB such as the Mantoux test, chest imaging, and ocular exams are also summarized.
This document provides an overview of keratoconus, including its etiology, signs and symptoms, classification, and management. Keratoconus is a non-inflammatory thinning of the cornea that results in a cone-shaped protrusion and irregular astigmatism. It typically onset in teenagers and progresses over time. Management includes rigid gas permeable contact lenses, collagen cross-linking to halt progression, and keratoplasty for advanced cases.
Cystoid macular edema is a pathological accumulation of fluid in the macula that can be caused by conditions like diabetic retinopathy, retinal vein occlusions, or following cataract surgery. It is diagnosed using optical coherence tomography or fluorescein angiography and treated initially with anti-inflammatory eye drops, corticosteroid injections, or anti-VEGF drugs to reduce fluid accumulation. Laser therapy or vitrectomy may also be used in some cases to treat underlying causes like vitreomacular traction.
This document discusses the classification and clinical approach to uveitis. It begins by classifying uveitis based on the primary site of inflammation - anterior, intermediate, posterior or panuveitis. It then describes the signs and symptoms of different types of uveitis such as anterior uveitis, chronic anterior uveitis, intermediate uveitis and posterior uveitis. It also discusses historical factors, investigations including serology, imaging and biopsy that are useful in diagnosing the cause of uveitis. It provides a flowchart for evaluation of a patient with anterior uveitis.
This document discusses uveal tract diseases, specifically uveitis (inflammation of the uveal tract). It defines posterior uveitis as inflammation of the choroid. Common causes of posterior uveitis include infectious diseases like tuberculosis, fungi, viruses, and parasites, as well as non-infectious conditions like autoimmune diseases. Symptoms include vision defects, flashes of light, and positive or negative scotomas. Signs include vitreous opacities, active or healed patches of choroiditis. Choroiditis is classified based on location and number of lesions, and can lead to complications if not treated properly with corticosteroids, immunosuppressants, or specific treatments for the
Corneal ectasias are a group of diseases characterized by corneal thinning and changes in shape. The main types are keratoconus, keratoglobus, and pellucid marginal degeneration. Keratoconus causes a cone-shaped protrusion of the cornea typically in the inferior region. It has a variety of signs on exam including Fleischer rings, Vogt's striae, and corneal scarring. Treatment involves contact lenses, intracorneal ring segments, corneal cross-linking, or transplantation. Keratoglobus is a non-progressive ectasia causing generalized thinning. Pellucid marginal degeneration causes a band of thinning separated from the limbus.
Coats' disease is a rare eye condition characterized by abnormal blood vessels in the retina. It most commonly affects young boys under 10 years old. The document discusses the history, signs and symptoms, classification, diagnosis, differential diagnosis, and management of Coats' disease. Treatment options depend on the stage of the disease and aim to obliterate abnormal retinal vessels using laser photocoagulation, cryotherapy, surgery, or newer adjunct treatments like intravitreal anti-VEGF agents. Indian studies found Coats' disease patients often present with more severe vision loss and extensive retinal involvement compared to other populations.
Central Retinal Artery Occlusion (CRAO) for undergraduate MBBS Students.
Covers the basics of Aetiology, pathophysiology, clinical features, types, associated conditions and management of CRAO.
Also encompasses salient points for PGMEE
The document discusses iridocorneal endothelial (ICE) syndrome, a rare disorder characterized by abnormalities of the corneal endothelium and iris that can cause corneal decompensation and glaucoma. ICE syndrome has three clinical variants (iris nevus/Cogan-Reese syndrome, Chandler syndrome, and essential/progressive iris atrophy) that are characterized by different degrees of iris atrophy. The pathogenesis involves proliferation of abnormal endothelial cells that migrate onto the trabecular meshwork and iris. Investigations include gonioscopy, ultrasound biomicroscopy, and specular microscopy of the corneal endothelium. Treatment involves medications and surgeries to manage glaucoma and corneal edema.
This document discusses intermediate uveitis (IU), specifically pars planitis. It defines IU as inflammation involving the anterior vitreous, peripheral retina, and ciliary body with minimal anterior segment signs. Pars planitis refers specifically to IU with snowbank or snowball formation in the absence of infection or systemic disease. The document provides details on epidemiology, pathogenesis, clinical signs, diagnostic testing, and management of IU and pars planitis. Treatment typically involves corticosteroids, with additional immunosuppressive therapies or surgery for refractory cases.
This document discusses cystoid macular edema (CME), including its pathogenesis, etiology, associated ocular conditions, manifestations, diagnosis and testing. Specifically, it focuses on pseudophakic or Irvine-Gass syndrome CME, which can occur after cataract surgery. The summary discusses how CME results from fluid accumulation in the retina, its appearance on fluorescein angiography, risk factors for pseudophakic CME like vitreous loss during surgery, and how it is diagnosed using techniques like optical coherence tomography.
1) VKH disease is a multisystem disorder characterized by granulomatous panuveitis with exudative retinal detachments and associated neurologic and cutaneous manifestations.
2) It was first described separately by three doctors (Vogt, Koyanagi, and Harada) in the early 20th century before being recognized as a single disease.
3) It has distinct prodromal, uveitic, chronic, and chronic recurrent stages with characteristic ocular and systemic findings at each stage. International criteria have been developed to classify its complete, incomplete, and probable forms.
Ophthalmic viscosurgical devices (OVDs) are used in eye surgeries to protect tissues and maintain spaces. Common OVDs include sodium hyaluronate, chondroitin sulfate, and hydroxypropyl methylcellulose. OVDs can be classified as cohesive, dispersive, or viscoadaptive based on their rheological properties such as viscosity and elasticity. Cohesive OVDs are highly viscous and stick together, while dispersive OVDs coat tissues well but are less viscous. OVDs are used in cataract surgery for tasks like protecting the endothelium, maintaining the anterior chamber, and implanting IOLs. Complications can include increased intraocular
This document discusses intermediate uveitis (IU), which involves inflammation in the anterior vitreous, pars plana, and peripheral retina. IU accounts for 8-22% of uveitis cases. Clinically, it is characterized by "snowballs" or yellow-white exudates in the peripheral vitreous. Treatment involves topical/periocular steroids initially, with cryotherapy, vitrectomy or immunosuppressants for non-responsive cases. Complications include cystoid macular edema, cataracts, glaucoma, and retinal detachment. Proper diagnosis requires excluding other causes like syphilis, Lyme disease, multiple sclerosis and sarcoidosis.
Intermediate uveitis is characterized by inflammation of the vitreous and peripheral retina. Symptoms include blurred vision, floaters, and decreased visual acuity. If left untreated, it can cause severe visual loss or sudden vision loss. Diagnosis is made based on the presence of vitreous cells and snowball or snowbank formations in the vitreous. Treatment involves systemic corticosteroids or immunosuppressive drugs to reduce inflammation. Additional treatments may include periocular corticosteroid injections, cryotherapy, or vitrectomy.
VKC is a chronic allergic inflammation of the ocular surface that is more common in children under 10 years of age. It involves the conjunctiva and cornea and causes symptoms like itching, redness, watering and sensitivity to light. Signs include thick mucus, transient yellow-white deposits called Horner-Tranta's dots, and large papillae on the conjunctiva that are graded based on their size. Corneal involvement can lead to punctate keratitis, erosions, ulcers and scarring if left untreated. The disease is seasonal in onset but may become perennial over time.
This document provides information on uveitis, including:
- Epidemiology data showing it is the third leading cause of blindness in developed countries, with highest rates in those over 65.
- Classification systems for uveitis based on location (anterior, intermediate, posterior, panuveitis) and duration (acute vs chronic).
- Signs and symptoms include redness, pain, photophobia, blurry vision, and floaters. Clinical signs depend on location and can include cells in the anterior chamber or snowballs in the vitreous.
- Differential diagnoses and specific types of non-infectious uveitis are discussed, including associations with autoimmune diseases like anky
This document provides guidance on diagnosing uveitis by discussing the following key points:
1. Uveitis is inflammation of the uvea that may involve surrounding structures. A thorough medical history and physical exam are essential to determine the etiology.
2. Uveitis is classified based on location (anterior, intermediate, posterior, or panuveitis), chronicity, granulomatous/non-granulomatous appearance, laterality, and demographic/symptom factors.
3. A comprehensive differential diagnosis is developed considering these classifications and laboratory/systemic evaluations to discern likely diagnoses, with an approach tailored to epidemiological data for the patient's demographic.
White dot syndromes are a group of diseases characterized by inflammation of the outer retina, retinal pigment epithelium, and choroid. They include conditions like birdshot retinochoroidopathy, multifocal choroiditis and panuveitis, and acute posterior multifocal placoid pigment epitheliopathy. Symptoms include blurred vision, photopsias, and visual field changes. Treatment involves corticosteroids and immunosuppressive drugs. Prognosis depends on the specific condition but many white dot syndromes resolve spontaneously without long-term vision loss.
Macular hole is a defect in the macula involving its full thickness. It was first described in 1869. Idiopathic macular holes are the most common type and affect people over age 55. Staging of macular holes ranges from stage 1 to 4 based on size and pathology. Symptoms include decreased vision and metamorphopsia. Diagnosis involves examination, OCT, and sometimes FA. Treatment is usually vitrectomy surgery for stages 2-4 to relieve traction on the macula. Prognosis depends on pre-op vision and hole size/duration, with most patients gaining vision after surgery.
Congenital retinal anomalies can arise from developmental defects, vascular abnormalities, infections, tumors or trauma. Clinical presentation depends on laterality and extent of vision loss. Examination may reveal colobomas, retinal folds, persistent fetal vasculature or lacunae indicative of conditions like Aicardi syndrome. Retinopathy of prematurity is a major cause of vision loss in premature infants and progresses through stages from demarcation lines to retinal detachment. Infectious etiologies can cause chorioretinitis from viruses like cytomegalovirus and parasites including toxoplasmosis. Prompt treatment is aimed at the underlying cause and prevention of complications affecting vision.
This document provides an overview of central serous chorioretinopathy (CSC), including its pathogenesis, clinical presentation, diagnosis, course and treatment. CSC is characterized by a localized serous retinal detachment in the macula due to leakage of fluid from the choroid. It typically affects men ages 30-50 and can be associated with stress, corticosteroid use, hypertension and type A personality. Diagnosis is usually clinical but can be confirmed with fluorescein angiography showing characteristic leakage patterns or optical coherence tomography identifying subretinal fluid. While most cases resolve spontaneously, laser photocoagulation or photodynamic therapy may be used in persistent or recurrent cases to seal leaking sites and accelerate resolution.
This document discusses ocular tuberculosis. It begins with an introduction to tuberculosis as a systemic disease caused by Mycobacterium tuberculosis. It then covers the clinical criteria for systemic TB disease and laboratory diagnostic criteria. It discusses the pathophysiology, transmission, and pathogenesis of TB infection. The document outlines various clinical presentations of ocular TB including anterior uveitis, intermediate uveitis, posterior segment manifestations, neuro-ophthalmic manifestations, adnexal involvement, and drug-related ocular toxicity. Investigations for diagnosing ocular TB such as the Mantoux test, chest imaging, and ocular exams are also summarized.
This document provides an overview of keratoconus, including its etiology, signs and symptoms, classification, and management. Keratoconus is a non-inflammatory thinning of the cornea that results in a cone-shaped protrusion and irregular astigmatism. It typically onset in teenagers and progresses over time. Management includes rigid gas permeable contact lenses, collagen cross-linking to halt progression, and keratoplasty for advanced cases.
Cystoid macular edema is a pathological accumulation of fluid in the macula that can be caused by conditions like diabetic retinopathy, retinal vein occlusions, or following cataract surgery. It is diagnosed using optical coherence tomography or fluorescein angiography and treated initially with anti-inflammatory eye drops, corticosteroid injections, or anti-VEGF drugs to reduce fluid accumulation. Laser therapy or vitrectomy may also be used in some cases to treat underlying causes like vitreomacular traction.
This document discusses the classification and clinical approach to uveitis. It begins by classifying uveitis based on the primary site of inflammation - anterior, intermediate, posterior or panuveitis. It then describes the signs and symptoms of different types of uveitis such as anterior uveitis, chronic anterior uveitis, intermediate uveitis and posterior uveitis. It also discusses historical factors, investigations including serology, imaging and biopsy that are useful in diagnosing the cause of uveitis. It provides a flowchart for evaluation of a patient with anterior uveitis.
This document discusses uveal tract diseases, specifically uveitis (inflammation of the uveal tract). It defines posterior uveitis as inflammation of the choroid. Common causes of posterior uveitis include infectious diseases like tuberculosis, fungi, viruses, and parasites, as well as non-infectious conditions like autoimmune diseases. Symptoms include vision defects, flashes of light, and positive or negative scotomas. Signs include vitreous opacities, active or healed patches of choroiditis. Choroiditis is classified based on location and number of lesions, and can lead to complications if not treated properly with corticosteroids, immunosuppressants, or specific treatments for the
Corneal ectasias are a group of diseases characterized by corneal thinning and changes in shape. The main types are keratoconus, keratoglobus, and pellucid marginal degeneration. Keratoconus causes a cone-shaped protrusion of the cornea typically in the inferior region. It has a variety of signs on exam including Fleischer rings, Vogt's striae, and corneal scarring. Treatment involves contact lenses, intracorneal ring segments, corneal cross-linking, or transplantation. Keratoglobus is a non-progressive ectasia causing generalized thinning. Pellucid marginal degeneration causes a band of thinning separated from the limbus.
Coats' disease is a rare eye condition characterized by abnormal blood vessels in the retina. It most commonly affects young boys under 10 years old. The document discusses the history, signs and symptoms, classification, diagnosis, differential diagnosis, and management of Coats' disease. Treatment options depend on the stage of the disease and aim to obliterate abnormal retinal vessels using laser photocoagulation, cryotherapy, surgery, or newer adjunct treatments like intravitreal anti-VEGF agents. Indian studies found Coats' disease patients often present with more severe vision loss and extensive retinal involvement compared to other populations.
Central Retinal Artery Occlusion (CRAO) for undergraduate MBBS Students.
Covers the basics of Aetiology, pathophysiology, clinical features, types, associated conditions and management of CRAO.
Also encompasses salient points for PGMEE
The document discusses iridocorneal endothelial (ICE) syndrome, a rare disorder characterized by abnormalities of the corneal endothelium and iris that can cause corneal decompensation and glaucoma. ICE syndrome has three clinical variants (iris nevus/Cogan-Reese syndrome, Chandler syndrome, and essential/progressive iris atrophy) that are characterized by different degrees of iris atrophy. The pathogenesis involves proliferation of abnormal endothelial cells that migrate onto the trabecular meshwork and iris. Investigations include gonioscopy, ultrasound biomicroscopy, and specular microscopy of the corneal endothelium. Treatment involves medications and surgeries to manage glaucoma and corneal edema.
This document discusses intermediate uveitis (IU), specifically pars planitis. It defines IU as inflammation involving the anterior vitreous, peripheral retina, and ciliary body with minimal anterior segment signs. Pars planitis refers specifically to IU with snowbank or snowball formation in the absence of infection or systemic disease. The document provides details on epidemiology, pathogenesis, clinical signs, diagnostic testing, and management of IU and pars planitis. Treatment typically involves corticosteroids, with additional immunosuppressive therapies or surgery for refractory cases.
This document discusses cystoid macular edema (CME), including its pathogenesis, etiology, associated ocular conditions, manifestations, diagnosis and testing. Specifically, it focuses on pseudophakic or Irvine-Gass syndrome CME, which can occur after cataract surgery. The summary discusses how CME results from fluid accumulation in the retina, its appearance on fluorescein angiography, risk factors for pseudophakic CME like vitreous loss during surgery, and how it is diagnosed using techniques like optical coherence tomography.
1) VKH disease is a multisystem disorder characterized by granulomatous panuveitis with exudative retinal detachments and associated neurologic and cutaneous manifestations.
2) It was first described separately by three doctors (Vogt, Koyanagi, and Harada) in the early 20th century before being recognized as a single disease.
3) It has distinct prodromal, uveitic, chronic, and chronic recurrent stages with characteristic ocular and systemic findings at each stage. International criteria have been developed to classify its complete, incomplete, and probable forms.
Ophthalmic viscosurgical devices (OVDs) are used in eye surgeries to protect tissues and maintain spaces. Common OVDs include sodium hyaluronate, chondroitin sulfate, and hydroxypropyl methylcellulose. OVDs can be classified as cohesive, dispersive, or viscoadaptive based on their rheological properties such as viscosity and elasticity. Cohesive OVDs are highly viscous and stick together, while dispersive OVDs coat tissues well but are less viscous. OVDs are used in cataract surgery for tasks like protecting the endothelium, maintaining the anterior chamber, and implanting IOLs. Complications can include increased intraocular
This document discusses intermediate uveitis (IU), which involves inflammation in the anterior vitreous, pars plana, and peripheral retina. IU accounts for 8-22% of uveitis cases. Clinically, it is characterized by "snowballs" or yellow-white exudates in the peripheral vitreous. Treatment involves topical/periocular steroids initially, with cryotherapy, vitrectomy or immunosuppressants for non-responsive cases. Complications include cystoid macular edema, cataracts, glaucoma, and retinal detachment. Proper diagnosis requires excluding other causes like syphilis, Lyme disease, multiple sclerosis and sarcoidosis.
Intermediate uveitis is characterized by inflammation of the vitreous and peripheral retina. Symptoms include blurred vision, floaters, and decreased visual acuity. If left untreated, it can cause severe visual loss or sudden vision loss. Diagnosis is made based on the presence of vitreous cells and snowball or snowbank formations in the vitreous. Treatment involves systemic corticosteroids or immunosuppressive drugs to reduce inflammation. Additional treatments may include periocular corticosteroid injections, cryotherapy, or vitrectomy.
VKC is a chronic allergic inflammation of the ocular surface that is more common in children under 10 years of age. It involves the conjunctiva and cornea and causes symptoms like itching, redness, watering and sensitivity to light. Signs include thick mucus, transient yellow-white deposits called Horner-Tranta's dots, and large papillae on the conjunctiva that are graded based on their size. Corneal involvement can lead to punctate keratitis, erosions, ulcers and scarring if left untreated. The disease is seasonal in onset but may become perennial over time.
This document provides information on uveitis, including:
- Epidemiology data showing it is the third leading cause of blindness in developed countries, with highest rates in those over 65.
- Classification systems for uveitis based on location (anterior, intermediate, posterior, panuveitis) and duration (acute vs chronic).
- Signs and symptoms include redness, pain, photophobia, blurry vision, and floaters. Clinical signs depend on location and can include cells in the anterior chamber or snowballs in the vitreous.
- Differential diagnoses and specific types of non-infectious uveitis are discussed, including associations with autoimmune diseases like anky
This document provides guidance on diagnosing uveitis by discussing the following key points:
1. Uveitis is inflammation of the uvea that may involve surrounding structures. A thorough medical history and physical exam are essential to determine the etiology.
2. Uveitis is classified based on location (anterior, intermediate, posterior, or panuveitis), chronicity, granulomatous/non-granulomatous appearance, laterality, and demographic/symptom factors.
3. A comprehensive differential diagnosis is developed considering these classifications and laboratory/systemic evaluations to discern likely diagnoses, with an approach tailored to epidemiological data for the patient's demographic.
Uveitis refers to inflammation of the uveal tract of the eye. It can be classified anatomically as affecting the anterior, intermediate, or posterior segments of the eye. Common causes include autoimmune disorders, infections, and neoplasms. Symptoms and signs depend on the location and severity of inflammation. Treatment involves topical or systemic corticosteroids and immunosuppressive medications. Complications can include vision loss if uveitis is not properly treated.
Uveitis is a general term for intraocular inflammation that does not indicate the specific site or cause of inflammation. It can be caused by autoimmune or infectious processes. Uveitis is a common cause of visual impairment and blindness worldwide. It is classified based on the site of inflammation - anterior, intermediate, posterior or panuveitis. Developing a differential diagnosis involves considering factors such as acuity of onset, laterality, associated symptoms and response to previous therapies. Common etiologies include idiopathic disease, infections like tuberculosis, and autoimmune diseases like sarcoidosis and Behcet's disease. Treatment involves corticosteroids and immunosuppressive therapies.
Retinal vasculitis is an inflammatory eye disease affecting the retinal vasculature. It can present as periphlebitis (vein involvement), periarteritis (artery involvement), or angiitis (both). Symptoms include gradual vision loss, floaters, photopsia, and scotomata. Signs include vascular sheathing, attenuation, hemorrhages, cotton-wool spots, and neovascularization. Causes include infectious etiologies like tuberculosis and syphilis, autoimmune diseases like sarcoidosis and Behcet's disease, and primary vasculitis like Eales' disease. Treatment involves managing underlying causes with medications like steroids, immunosuppressants,
Uveitis refers to inflammation of the uveal tract of the eye. It can be caused by infections, autoimmune disorders, trauma, medications, or rarely malignancies. It is a leading cause of blindness worldwide. Symptoms and signs depend on the location and severity of inflammation in the eye. Examination findings provide clues to the etiology and classification of uveitis. A thorough history and comprehensive ocular examination are important for diagnosis and management.
Uveitis refers to inflammation within the eye and is a leading cause of blindness. It was once considered a single disease but is now known to have various causes, including autoimmune disorders, infections, malignancy, and toxoplasmosis. A thorough evaluation including history, examination, and testing is needed to determine the extent, structures affected, underlying cause, and best treatment. Treatment involves topical steroids as first line but may require periocular injections or oral steroids depending on severity and location of inflammation. Long term management balances control of inflammation with risks of treatment side effects like increased eye pressure.
This document provides information on uveitis, including epidemiology, pathophysiology, classification, symptoms, clinical signs, grading, etiologies, and differential diagnoses. Some key points:
- Uveitis affects approximately 15 per 100,000 people in the US each year and is a leading cause of blindness. It is more common in those over 65, females, and presents as chronic and unilateral inflammation.
- Uveitis results from inflammation of the uveal tract (iris, ciliary body, choroid) which can be infectious, autoimmune, traumatic, or idiopathic in nature. This causes an inflammatory cascade in the eye.
- It is classified based on location (
Uveitis refers to inflammation of the uveal tract of the eye. It can be caused by infections, autoimmune disorders, or malignancies. Uveitis is classified anatomically by the area of inflammation - anterior, intermediate, posterior, or panuveitis. It is also classified clinically based on duration and course. Anterior uveitis presents with pain, photophobia, redness, and blurred vision. Signs include cells and flare in the anterior chamber, keratic precipitates, and iris lesions. Intermediate uveitis affects the vitreous and peripheral retina. Posterior uveitis causes floaters and fundus lesions. Management involves identifying the etiology, using topical and systemic st
Evaluation of White Pupillary Reflex FINAL.pptxMahfuz Shohag
Leukocoria or white pupillary reflex can be caused by several conditions. The differential diagnosis can be narrowed through history, examination, and investigations. The main differentials discussed were congenital cataract, retinoblastoma, persistent hyperplastic primary vitreous, ocular toxocariasis, Coat's disease, retinopathy of prematurity, and coloboma. Early diagnosis is important as treatment can help save vision for many of these conditions causing leukocoria.
This document summarizes the clinical classification and investigations for uveitis. It divides uveitis into infectious and non-infectious categories. Infectious uveitis can be bacterial, viral, fungal or parasitic in origin. Non-infectious uveitis is further divided into those with a known systemic association and those without. Investigations may include blood tests, imaging like ultrasound and angiography, aqueous or vitreous taps, and biopsies depending on the severity, recurrence and presence of granulomatous signs. Specific tests are aimed at identifying underlying infectious or inflammatory diseases. A thorough history and examination provide important clues to guide appropriate investigations.
This document summarizes different types of uveitis:
1) Glaucomatocyclitic crisis causes recurrent mild iritis with elevated IOP treated with steroids and IOP medications.
2) Lens-associated uveitis occurs after lens disruption/leakage and shows anterior uveitis with KPs and elevated IOP treated with steroids.
3) Fuchs heterochromic iridocyclitis is usually unilateral with diffuse iris atrophy, KPs, and heterochromia treated with steroids.
This document provides information on Vogt-Koyanagi-Harada Syndrome (VKH) and Behcet's Disease. It discusses the epidemiology, pathogenesis, clinical features, diagnosis, and treatment of both conditions. VKH is an autoimmune disease affecting melanocytes in the skin, eyes, inner ears, and brain. It presents with uveitis, hearing loss, neurological symptoms, and depigmentation. Behcet's disease is a systemic vasculitis of unknown origin that can cause oral ulcers, skin lesions, genital ulcers, arthritis, and ocular inflammation.
The white dot syndromes are a group of diseases characterized by inflammation of the outer retina, retinal pigment epithelium, and choroid. They include birdshot retinochoroidopathy, multifocal choroiditis and panuveitis, punctate inner choroidopathy, subretinal fibrosis and uveitis syndrome, multiple evanescent white dot syndrome, acute posterior multifocal placoid pigment epitheliopathy, and serpiginous choroidopathy. The etiology is unknown but may be autoimmune or infectious. Patients typically present with blurred vision, photopsias, and floaters. Examinations reveal multiple cream-colored lesions throughout the fundus. Treatment involves corticosteroids and immunosuppress
Sarcoidosis is a multisystem inflammatory disease characterized by the formation of non-caseating granulomas in multiple organs. Ocular involvement occurs in 25-60% of sarcoidosis patients and most commonly manifests as chronic anterior uveitis. The document outlines the definition, epidemiology, pathogenesis, clinical features involving the eyes and other organ systems, diagnostic criteria, treatment, and complications of ocular sarcoidosis. Investigations like lab tests, imaging, and biopsy are used to diagnose sarcoidosis and rule out other differentials when the clinical features are present.
Sarcoidosis is a multisystem inflammatory disease characterized by the formation of non-caseating granulomas in multiple organs. Ocular involvement occurs in 25-60% of sarcoidosis patients and most commonly manifests as chronic anterior uveitis. Other ocular features include conjunctival and lacrimal gland nodules, keratitis, optic neuropathy, and posterior uveitis. Systemic features commonly involve the lungs, skin, and lymph nodes. Investigations include blood tests, imaging, and tissue biopsy demonstrating granulomas. Treatment involves topical or oral corticosteroids and immunosuppressants. Complications include cataracts, glaucoma, cystoid macular edema,
Pars Planitis is a disease of the eye that is characterized by inflammation of the narrowed area (pars plana) between the colored part of the eye (iris) and the choroid. This may lead to blurred vision; dark, floating spots in the vision; and progressive vision loss.
Orientation,history taking and examinatio.pptsultanovasits
The document outlines an orientation course for ophthalmology residents that covers various topics including history taking, examination techniques, common diseases and emergencies. It details the objectives of the course, components such as lectures and clinical sessions, assessment methods, recommended textbooks and electronic resources. Key examination techniques discussed include visual acuity testing, external eye examination, motility evaluation, slit lamp biomicroscopy, tonometry and ophthalmoscopy.
Uveitis is classified based on the primary site of inflammation in the eye: anterior, intermediate, posterior, or panuveitis. It is also described based on clinical features like onset, duration, and course. A thorough evaluation is needed to categorize uveitis and identify any underlying etiology, as it can be associated with systemic diseases. A standardized system of nomenclature exists to describe uveitis uniformly based on anatomy, activity, and other characteristics. Symptoms depend on the location and severity of inflammation, and may include pain, photophobia, blurred vision, or floaters.
This document discusses uveitis in systemic diseases. It begins with an introduction defining the uvea and uveitis. It then discusses how uveitis can be associated with various systemic diseases and the importance of a thorough history and physical exam. The document outlines various classifications of uveitis and clinical features. It then discusses principles of diagnosis and treatment of uveitis in specific systemic diseases like spondyloarthropathies, juvenile idiopathic arthritis, Behcet's disease, sarcoidosis, and others. It describes characteristics, investigations and management considerations for uveitis related to these systemic conditions.
Similar to Approach to posterior uveitis final modified (20)
Lecture 6 -- Memory 2015.pptlearning occurs when a stimulus (unconditioned st...AyushGadhvi1
learning occurs when a stimulus (unconditioned stimulus) eliciting a response (unconditioned response) • is paired with another stimulus (conditioned stimulus)
Histololgy of Female Reproductive System.pptxAyeshaZaid1
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
Travel Clinic Cardiff: Health Advice for International TravelersNX Healthcare
Travel Clinic Cardiff offers comprehensive travel health services, including vaccinations, travel advice, and preventive care for international travelers. Our expert team ensures you are well-prepared and protected for your journey, providing personalized consultations tailored to your destination. Conveniently located in Cardiff, we help you travel with confidence and peace of mind. Visit us: www.nxhealthcare.co.uk
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdfrightmanforbloodline
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
These lecture slides, by Dr Sidra Arshad, offer a simplified look into the mechanisms involved in the regulation of respiration:
Learning objectives:
1. Describe the organisation of respiratory center
2. Describe the nervous control of inspiration and respiratory rhythm
3. Describe the functions of the dorsal and respiratory groups of neurons
4. Describe the influences of the Pneumotaxic and Apneustic centers
5. Explain the role of Hering-Breur inflation reflex in regulation of inspiration
6. Explain the role of central chemoreceptors in regulation of respiration
7. Explain the role of peripheral chemoreceptors in regulation of respiration
8. Explain the regulation of respiration during exercise
9. Integrate the respiratory regulatory mechanisms
10. Describe the Cheyne-Stokes breathing
Study Resources:
1. Chapter 42, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 36, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 13, Human Physiology by Lauralee Sherwood, 9th edition
How to Control Your Asthma Tips by gokuldas hospital.Gokuldas Hospital
Respiratory issues like asthma are the most sensitive issue that is affecting millions worldwide. It hampers the daily activities leaving the body tired and breathless.
The key to a good grip on asthma is proper knowledge and management strategies. Understanding the patient-specific symptoms and carving out an effective treatment likewise is the best way to keep asthma under control.
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptxHolistified Wellness
We’re talking about Vedic Meditation, a form of meditation that has been around for at least 5,000 years. Back then, the people who lived in the Indus Valley, now known as India and Pakistan, practised meditation as a fundamental part of daily life. This knowledge that has given us yoga and Ayurveda, was known as Veda, hence the name Vedic. And though there are some written records, the practice has been passed down verbally from generation to generation.
low birth weight presentation. Low birth weight (LBW) infant is defined as the one whose birth weight is less than 2500g irrespective of their gestational age. Premature birth and low birth weight(LBW) is still a serious problem in newborn. Causing high morbidity and mortality rate worldwide. The nursing care provide to low birth weight babies is crucial in promoting their overall health and development. Through careful assessment, diagnosis,, planning, and evaluation plays a vital role in ensuring these vulnerable infants receive the specialize care they need. In India every third of the infant weight less than 2500g.
Birth period, socioeconomical status, nutritional and intrauterine environment are the factors influencing low birth weight
Nano-gold for Cancer Therapy chemistry investigatory projectSIVAVINAYAKPK
chemistry investigatory project
The development of nanogold-based cancer therapy could revolutionize oncology by providing a more targeted, less invasive treatment option. This project contributes to the growing body of research aimed at harnessing nanotechnology for medical applications, paving the way for future clinical trials and potential commercial applications.
Cancer remains one of the leading causes of death worldwide, prompting the need for innovative treatment methods. Nanotechnology offers promising new approaches, including the use of gold nanoparticles (nanogold) for targeted cancer therapy. Nanogold particles possess unique physical and chemical properties that make them suitable for drug delivery, imaging, and photothermal therapy.
10 Benefits an EPCR Software should Bring to EMS Organizations Traumasoft LLC
The benefits of an ePCR solution should extend to the whole EMS organization, not just certain groups of people or certain departments. It should provide more than just a form for entering and a database for storing information. It should also include a workflow of how information is communicated, used and stored across the entire organization.
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPsychoTech Services
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
Know the difference between Endodontics and Orthodontics.Gokuldas Hospital
Your smile is beautiful.
Let’s be honest. Maintaining that beautiful smile is not an easy task. It is more than brushing and flossing. Sometimes, you might encounter dental issues that need special dental care. These issues can range anywhere from misalignment of the jaw to pain in the root of teeth.
2. Introduction
• Inflammation of Retina or Choroid
• Isolated Posterior Uveitis (PU) (20-30%)
• PU associated with Anterior Uveitis (Panuveitis 10-20%)
• Serious Sight Threatening Condition !
• It is considered to be the fourth most common cause
of blindness in individuals 20 to 60 years of age in
developed countries
• (64% of cases of Posterior Uveitis associated with
visiual impairment)
• Reference : O M Durrani, N N Tehrani and P I Murray
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1772296/#
3. Introduction
• Proper Clinical Assessment ; essential in:
• Narrowing the differential diagnosis and providing clues for the
final diagnosis (infectious vs non-infectious vs masqueraders)
• Guiding the diagnostic work-up (imaging, extraocular evaluation
and laboratory testing)
• Evaluating disease activity and severity
4. Etiology of Posterior Uveitis
• We can establish a diagnosis in 80% of cases of Posterior Uveitis.
• Primary Ocular Uveitis
1. White Dot Syndromes
2. Sympathetic Ophthalmia
• Systemic Disease
1. Behcet Disease
2. Sarcoid
3. VKH
• Infectious Disease
1. Tuberculosis
2. Syphilis
3. Toxoplasmosis
4. HSV, CMV
5. Important Questions that should be answered in PU
1. Is it Posterior Uveitis only or is it part of a Panuveitis?
2. Is it Choroiditis, Retinitis, or Retinochoroiditis?
3. Is there associated involvement of the Optic Nerve Head and/or Retinal vessels?
4. Does the clinical feature fit into any known infective or non-infective entity?
5. Is it associated with other systemic features?
6. Is it recurrent? If so, how has it responded to previous therapy?
7. Is it associated with immunocompromised status?
8. Is it a masquerade syndrome?
6. History Taking
• Present Illness: laterality, onset, course, ocular symptoms, treatment
• Demographic data: age, sex, ethnicity
• Geographic history: birthplace, residency location, travel
• Past ocular history: previous episodes, past therapy and response,
previous ocular trauma and surgery
• Medical history: Systemic illness, Immune status , medications
• Social history: dietary habits, sexual history, intravenous drug abuse,
social habits(Alcohol & Smoking)
• Family history: medical illnesses, contagious disease
(Tuberculosis),maternal infections, history of Uveitis
7. Review of Medical Systems
• General: Fever, weight loss, malaise, night sweats
• Rheumatologic: arthralgia, joint stiffness
• Dermatologic: rashes, sores, alopecia, vitiligo, poliosis, tick/insect
bites
• Neurologic: tinnitus, meningism , Cranial neuropathies
paresthesia, weakness/paralysis
• Respiratory: Shortness of breath, cough, sputum production
• Gastrointestinal: Diarrhea, bloody stool, oral aphthous ulcer
• Genitourinary: dysuria, discharge, genital ulcer, balanitis
8. Ocular Examination
1. Visual acuity measurement
2. Evaluation of associated anterior segment inflammatory signs: non-
granulomatous vs granulomatous, hypopyon, ocular hypertension)
3. Measurement of Intraocular pressure (IOP); Rise in IOP is associated with
Toxoplasmosis, HSV
4. Qualitative and Quantitative assessment of posterior segment inflammatory
signs:
-Vitreous cells and haze
-Fundus changes: Retinal and Choroidal lesions
Retinal Vasculitis
Macular Edema, other macular changes
Optic disc changes
9. Investigations
1. Rationale;
• Do we need to do investigations in every case of
Posterior Uveitis?
2. Investigations for diagnosis
3. Investigations for monitoring
a-Activity
b-Damage
C-side effects of medications
10. Diagnostic Investigations
• Hierarchy
• None Some Diseases with clear diagnosis like toxoplasmosis may
require no diagnostic investigations, also known history of
systemic diseases that may cause uveitis like behcet and sarcoid.
• Standard Some non-invasive investigations may be appropriate
in almost all posterior segment Uveitis
• Targeted Some posterior segment Uveitis may warrant additional
tests in a targeted manner
14. Characterization of Posterior Uveitis (PU)
• Onset/Course
• Signs & symptoms
• Laterality
• Degree of Vitritis
• Primary site of inflammation
• Morphologic Characteristics
Important clues for the differential diagnosis
15. Onset and Course
• Sudden Think of Infectious causes
• Insidious Think of non infectious causes
16. Duration of Uveitis
• Acute Uveitis: episodes of sudden onset and limited duration that
usually resolves within 3 months or less
• Chronic Uveitis: persistent, with relapse occurring in less than 3
months after discontinuing treatment
• Recurrent Uveitis: repeated episodes separated by periods of
inactivity without treatment that lasts 3 months or longer
17. Symptoms and Signs of Posterior Uveitis
• 6 Symptoms include:
1. Painless decreased visual acuity
2. Floaters
3. Photopsia
4. Metamorphopsia
5. Scotoma
6. Nyctalopia
• 6 Signs include:
1. Retinal or Choroidal
inflammatory infiltrates
2. Inflammatory sheathing of
arteries or veins
3. Exudative retinal detachment
4. RPE atrophy or hypertrophy
5. Atrophy or swelling of the Optic
nerve head, retina or choroid
6. Choroidal or retinal
neovascularization
7. Macular edema
25. DDx of Focal chorioretinal lesions
A. With vitreal cells: toxoplasmosis, sarcoid, TB, Toxocariasis.
B. Without vitreal cells: tumours, serpiginous choroidopathy.
26. Differential Diagnosis of Peripheral Multifocal
chorioretinal lesions
A. With vitreal cells: sarcoid, BSCR, MCP, SO, VKH, MEWDS,
Masquerade.
B. Without vitreal cells: POHS, PIC, APMPPE
28. Can differentiate MFC vs PIC vs POH
Ocular Histoplasmosis
SyndromePunctate Inner
Choroidopathy
Caucasian; 20 to 50 years of age
Classic Triad:
1.Multiple choroidal spots
(“histo” spots)
2.Peripapillary changes
3.CNV or disciform scar
4.NO VITRITIS !
Women, 20-50 years of
age
Bilateral , yellowish-white
choroidal infiltrates
+
With Vitritis !
Women, Myopia
Uni or Bilateral small
yellow-whit deep lesions
in the posterior pole
+
No Vitritis
Multifocal Choroiditis
with Panuveitis
31. Diffuse Choroiditis
• Bilateral posterior or
Panuveitis with multifocal
serous retinal detachment in
a young darkly pigmented
patient
Acute Vogt-Koyanagi-Harada
Disease
34. (Morphologic Characteristics
Associated Macular Edema)
• May occur in any form of
Uveitis in the following order
from most common ( % ) :
1. Panuveitis 53%
2. Intermediate Uveitis 41%
3. Posterior Uveitis 28%
4. Anterior Uveitis 9%
• Diagnosis is based on:
1. Clinical examination +
2. Fluorescein angiography ++
3. OCT +++
39. Necrotizing Retinitis
(Associated with immunosuppression)
• AIDS
• After Renal
transplantation
• After intravitreal
corticosteroid therapy
CMV RETINITIS
43. General Guidelines
• 1.Infectious cause : treat the infection
• Antibiotic therapy
• Steroids is prescribed after 48 hours of starting antibiotics
• 2. Non infectious cause:
. Give systemic steroid
44. In CAU and Post NIU
Oral
steroids
MTX VS Cellcept VS
Azathioprine
Cyclosporin
Infliximab
(Remicade)
Humira
(adalimumab)
45. Posterior non infectious uveitis
• Local treatment with steroids (PSK, Ozurdex,Retisert)
is preferred in:
Poor compliance with treatment
unilateral cases
Poor tolerance to systemic medications
46. Recommendations
• Never give periocular steroid injection before excluding
Infectious causes of Posterior Uveitis first.
• Start with Empirical therapy for Posterior Uveitis till the results
of the investigation are obtained.
• If there is worsening in the patient condition after giving steroid,
review the diagnosis and think of Infectious causes
• If there is no response after 2 weeks of steroid use, think of
Masquerade diseases (Lymphoma) Vs infectious cause
47. CONCLUSIONS
• Appropriate approach to the diagnosis of Posterior Uveitis:
1. Meticulous history taking and systemic examination
2. Proper analysis of ocular clinical and imaging findings
3. Tailored laboratory evaluation (limited number of tests)
• Leads to the correct diagnosis in the majority of patients
• Diagnosis may be challenging in atypical clinical presentations:
need for extensive diagnostic work-up
Posterior Uveitis: intraocular inflammation primarily involving the retina and/ or the choroid
Panuveitis: inflammation is diffuse without a predominant site. Inflammation is observed in the anterior chamber , vitreous, and retina and/or choroid
Retinochoroiditis: inflammation of the retina extending to the choroid
The Uveitis Masquerade Syndromes (UMS) are a group of various ocular diseases that may mimic chronic intraocular inflammation.
Cigarette smoking is significantly associated with new onset uveitis within a population-based setting. The association was stronger for non-infectious uveitis.Mar 30, 2015
www.ncbi.nlm.nih.gov › pmc › articles › PMC4446169
Alcohol to monitor therapy that affect Liver function
Q. Do we need to do investigations in every case of PU?
A. Yes we do, except, if we have clear clinical diagnosis exemplified by Toxoplasma scar
QuantiFERON-TB Gold (QFT) is a simple blood test that aids in the detection of Mycobacterium tuberculosis, the bacteria which causes tuberculosis (TB). QFT is an interferon-gamma (IFN-γ) release assay, commonly known as an IGRA, and is a modern alternative to the tuberculin skin test (TST, PPD or Mantoux)
PPD is positive in BCG vaccinated patient
Quantiferon is only positive if past or current exposure to TB
QFT-G has much higher sensitivity than TST for active pulmonary tuberculosis. It is unaffected by prior BCG administration and prior exposure to atypical mycobacteria. A positive QFT-G result can be an adjunct to diagnosis in patients having clinical and radiological data compatible with pulmonary tuberculosis.
Neuroretinitis is an inflammation of the neural retina and optic nerve.
Anti-double stranded DNA (Anti-dsDNA) antibodies are a group of anti-nuclear antibodies (ANA) the target antigen of which is double stranded DNA. Blood tests such as enzyme-linked immunosorbent assay (ELISA) and immunofluorescence are routinely performed to detect anti-dsDNA antibodies in diagnostic laboratories.
ELISA (enzyme-linked immunosorbent assay) is a plate-based assay technique designed for detecting and quantifying substances such as peptides, proteins, antibodies and hormones.
-Photopsia is the presence of flashes of light or floaters in the vision. ..
the perception of light (as luminous rays or flashes) that is purely subjective and accompanies a pathological condition especially of the retina or brain.
-Floater: A blurry spot that seems to drift in front of the eyes but does not block vision
-Metamorphopsia is a type of distorted vision in which a grid of straight lines appears wavy and parts of the grid may appear blank.
-Scotoma is an area of partial alteration in the field of vision consisting of a partially diminished or entirely degenerated visual acuity that is surrounded by a field of normal – or relatively well-preserved – vision
Night blindness, impaired vision in dim light and in the dark, due to impaired function of certain specialized vision cells (the rods) in the retina.
Cell (1x3 mm beam in anterior vitreous)
Trace 0-10 cells
1+ 10-20
2+ 20-30
3+ 30-100
4+ > 100 cells
Flare (Vitreous Haze)
0 Good View of NFL
1+ Clear ON & vessels but hazy NFL
2+ ON & vessels hazy
3+ ON only
4+ No ON
Retinochoroiditis : inflammation mainly in retina extending to choroid
Retinitis :Fluffy white retina with diffuse borders and lots of vitritis.
Example:
Monofocal retinitis: Toxoplasmosis, toxocara, masquerade
Multifocal retinitis : ARN, Sarcoidosis, Syphilis
Choroiditis: Yellow with demarcated borders and no or minimal vitritis
Focal: With vitreal cells: toxoplasmosis, sarcoid, TB, Toxocariasis
Focal without Vitreal cells : tumours, serpiginous choroidopathy.
Retinal Vasculitis: defined by the presence of retinal vascular changes in association with ocular inflammation
Blood vessel changes include perivascular sheathing and vascular leakage or occlusion shown on FFA
Optic nerve head granuloma as a primary manifestation of ocular sarcoidosis - A tertiary uveitis clinic experienceSudha K Ganesh, Anushree Vijay Kaduskar
Differentiate by history of travel to Mississpy river
Change PIC picture to similar one to Ocular histoplasmosis
MF Chorioretinal Lesions
With vitreal cells: BSCR, MCP, SO, VKH, MEWDS, Masquerade.
Without vitreal cells: POHS, PIC, APMPPE
chorioretinal lesions and vitreous cells were described with what was termed "pseudo-POHS" because the chorioretinal lesions resembled those observed in patients with presumed ocular histoplasmosis.
Picture 2 shows sympathetic ophthalmia retina. Yellow-white subretinal spots (arrows) on clinical fundus photographs correspond to histopathological Dalen-Fuchs nodules and choroidal infiltrates
Choice depends on the clinical condition
Pregnant lady we cant give MTX only Imuran is indicated
Patient having side effect from one medication, we have choice to change therapy
Patient preference!! MTX given once every week vs daily dose of Cellcept or Imuran
Cellcept : mycophenolate mofetil
Masquerade: condition that mimic Uveitis but its not true Uveitis like lymphoma and leukemia